Ciphergen Biosystems, Inc.

Data on disease-specific inflammatory diagnostics reported at cancer meeting

Published in Patient Care Law Weekly, May 2nd, 2004

Ciphergen Biosystems, Inc., (CIPH), in conjunction with the Johns Hopkins University School of Medicine, presented data at the American Association for Cancer Research (AACR) 95th annual meeting in Orlando, Florida, describing a novel approach to diagnostics based on the detection of combinations of protein fragments associated with the inflammatory response to disease.

Ciphergen and its collaborators reported that different diseases generate unique host responses that can be distinguished by the quantitative detection of disease-specific protein fragments, potentially opening up a novel approach to multi-biomarker diagnostics. Ciphergen has applied for patents on this...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Patient Care Law Weekly

Source: Patient Care Law Weekly (2004-05-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry